首页> 外国专利> TREATING HEPATITIS C VIRUS INFECTION WITH OVER-EXPRESSION OF MICRORNA-196.

TREATING HEPATITIS C VIRUS INFECTION WITH OVER-EXPRESSION OF MICRORNA-196.

机译:过度表达MICRORNA-196治疗肝炎C病毒感染。

摘要

The present invention is directed to methods of treating cells infected with HCV and mammals suffering from HCV infection by transfecting the infected cells with miRNA-196 mimic. miRNA-196 mimic significantly down-regulates Bach1 protein and HCV gene expression, while also up-regulating HMOX1 gene expression. miRNA-196 binds with the 3'-UTR of Bach1 mRNA to reduce the expression of Bach1. As such, miRNA-196 can play an important role in the regulation of HCV replication and HMOX1/Bach1 expression in hepatocytes. The present invention also provides a formulation for the treatment of cells expressing HCV comprising a therapeutically effective amount of miRNA-196 such that Bach1 and HCV gene expression are down- regulated while HMOX1 expression is increased. The formulations are adapted to enable the transfection of miRNA-196 mimic into hepatocytes expressing HCV proteins.
机译:本发明涉及通过用miRNA-196模拟物转染感染的细胞来治疗被HCV感染的细胞和患有HCV感染的哺乳动物的方法。 miRNA-196模拟物显着下调Bach1蛋白和HCV基因表达,同时也上调HMOX1基因表达。 miRNA-196与Bach1 mRNA的3'-UTR结合以减少Bach1的表达。因此,miRNA-196在肝细胞中HCV复制和HMOX1 / Bach1表达的调节中起着重要作用。本发明还提供了用于治疗表达HCV的细胞的制剂,该制剂包含治疗有效量的miRNA-196,使得Bach1和HCV基因的表达下调而HMOX1的表达增加。所述制剂适于使miRNA-196模拟物转染到表达HCV蛋白的肝细胞中。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号